- Country: Russia
- Summary: Supply of Medicines not Included in the List of Vital and Essential Drugs (Gentamicin Dexpanthenol Mometasone Econazole) for the Needs of Gbuz Pk "Kkkvd
- RUT Ref No: 79306462
- Deadline: 02 Mar 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RUB 199950.00
- Notice Type: Tender
- Document Ref. No.: 0356500000223000031
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Supply of medicines not included in the list of Vital and Essential Drugs (Gentamicin Dexpanthenol Mometasone Econazole) for the needs of GBUZ PK "KKKVD
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of Medicines not Included in the List of Vital and Essential Drugs (Gentamicin Dexpanthenol Mometasone Econazole) for the Needs of Gbuz Pk "Kkkvd - Russia Tender
The STATE BUDGETARY INSTITUTION OF HEALTH CARE OF THE PERM REGION "REGIONAL CLINICAL SKIN AND VENEREOLOGICAL DISPENSARY, a Government sector organization in Russia, has announced a new tender for Supply of Medicines not Included in the List of Vital and Essential Drugs (Gentamicin Dexpanthenol Mometasone Econazole) for the Needs of Gbuz Pk "Kkkvd. This tender is published on RussiaTenders under RUT Ref No: 79306462 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-03-02.
The estimated tender value is RUB 199950.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
